← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2001First marketed drug
Nov 18, 2004First NDA
Nov 18, 2004Last known activity
Dec 1, 2013
Acquired by Astellas → Leo Pharma on Jun 9, 2010
Timeline
1980s
- Jan 1, 1983
OSI Pharmaceuticals— Founded
2000s
- Jun 12, 2003
Cell Pathways, Inc.— Acquired
- Nov 18, 2004
erlotinib— NDA Organization
2010s
- Jun 9, 2010
Astellas— Acquired By
- Nov 17, 2015
Leo Pharma— Now
Drugs by trial phase (39 distinct, 76 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma of Lung
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Crohn Disease
- Ependymoma
- Esophageal Neoplasms
- Exanthema
- Glioblastoma
- Glioma
- Gliosarcoma
- Head and Neck Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Acute
- Liver Neoplasms
- Lung Neoplasms
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Squamous Cell
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pharyngeal Neoplasms
- Polycythemia
- Polycythemia Vera
- Prostatic Neoplasms
- Psoriasis
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT01927744CollaboratorPhase 2Dec 1, 2013
- NCT01427205CollaboratorPhase 2Jun 1, 2013
- NCT01257594CollaboratorN/AJan 1, 2013
- NCT01567384CollaboratorPhase 1May 1, 2012
- NCT01247922Lead sponsorPhase 2May 1, 2011
- NCT01180959CollaboratorPhase 2Apr 1, 2011
- NCT01198028CollaboratorPhase 2Mar 1, 2011
- NCT01334710CollaboratorPhase 2Mar 1, 2011
- NCT01059305CollaboratorPhase 2Feb 1, 2011
- NCT01299220CollaboratorPhase 4Nov 1, 2010
- NCT01032070Lead sponsorPhase 2Sep 1, 2010
- NCT01154335CollaboratorPhase 1Jul 1, 2010
- NCT01174043CollaboratorPhase 2Jul 1, 2010
- NCT01064479CollaboratorPhase 2Feb 1, 2010
- NCT01027598CollaboratorPhase 2Jan 1, 2010
Details
- Founded
- Melville, NY, US Jan 1, 1983
- First NDA
- Nov 18, 2004
- Last known activity
- Dec 1, 2013
Designations held
- Fast track
- Priority review
Notes
Acquired by Astellas